{"date":"2026-08-19","count":10,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6734-2026-08-19-1921-bm3bd3","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2026-08-19","time":"19:21:06","subject":"公告本公司擬申請115年現金增資調整發行股數及募集金額","clause":"第44款","fact_date":"2026-08-19","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2026-08-19 19:21，「公告本公司擬申請115年現金增資調整發行股數及募集金額」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2026-08-19-1816-fuohkz","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2026-08-19","time":"18:16:19","subject":"公告本公司董事會決議買回庫藏股 (更正買回股份總金額上限及轉讓辦法)","clause":"第35款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：大江（8436），2026-08-19 18:16，「公告本公司董事會決議買回庫藏股 (更正買回股份總金額上限及轉讓辦法)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-08-19-1633-1oixrch","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-08-19","time":"16:33:25","subject":"公告本公司發言人異動事宜","clause":"第11款","fact_date":"2026-08-19","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-08-19 16:33，「公告本公司發言人異動事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-08-19-1615-17red0q","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-08-19","time":"16:15:30","subject":"公告本公司新任研發長事宜","clause":"第11款","fact_date":"2026-08-19","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-08-19 16:15，「公告本公司新任研發長事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-08-19-1614-gey8f1","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-08-19","time":"16:14:52","subject":"公告本公司總經理異動事宜","clause":"第6款","fact_date":"2026-08-19","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-08-19 16:14，「公告本公司總經理異動事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2026-08-19-1608-126tsyk","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2026-08-19","time":"16:08:34","subject":"公告本公司董事會決議發行國內第一次有擔保轉換公司債","clause":"第11款","fact_date":"2026-08-19","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2026-08-19 16:08，「公告本公司董事會決議發行國內第一次有擔保轉換公司債」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-08-19-1555-1x28qgs","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-08-19","time":"15:55:41","subject":"本公司向台灣衛生福利部食品藥物管理署（TFDA）遞交前列腺癌新劑量新藥「康紓維(柳菩林)21毫克注射乳劑；CAMCEVI 21 mg」查驗登記申請","clause":"第10款","fact_date":"2026-08-19","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-08-19 15:55，「本公司向台灣衛生福利部食品藥物管理署（TFDA）遞交前列腺癌新劑量新藥「康紓維(柳菩林)21毫克注射乳劑；CAMCEVI」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-08-19-1549-15z3la7","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-08-19","time":"15:49:24","subject":"更正本公司115年第2季iXBRL合併財務報告之部分資訊","clause":"第53款","fact_date":"2026-08-19","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-08-19 15:49，「更正本公司115年第2季iXBRL合併財務報告之部分資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-08-19-1516-1b79ixs","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-08-19","time":"15:16:08","subject":"本公司「闌尾炎檢測系統」(EFAI ERSUITE CT APPENDICITIS ASSESSMENT SYSTEM）獲得衛生福利部食品藥物管理署(TFDA)醫療器材許可證核准通知","clause":"第53款","fact_date":"2026-08-19","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-08-19 15:16，「本公司「闌尾炎檢測系統」(EFAI ERSUITE CT APPENDICITIS ASSESSMENT SYSTEM）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-08-19-1503-15z3la7","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-08-19","time":"15:03:59","subject":"更正本公司115年第2季iXBRL合併財務報告之部分資訊","clause":"第53款","fact_date":"2026-08-19","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-08-19 15:03，「更正本公司115年第2季iXBRL合併財務報告之部分資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}